2023
Entrant Company
Category
Client's Name
Country / Region
Inceptor Bio is a pre-clinical cell therapy company that is shifting its focus from CAR-T, CAR-M, CAR-NK, IPSC and manufacturing to exclusively CAR-M. The goal of this project was to share Inceptor’s latest CAR-M data package and clearly explain the advantages of Inceptor Bio's CAR-M therapy on solid tumors to potential investors and partners.
Credits